Shivalik Rasayan Ltd Share Price

Overview

Shivalik Rasayan Ltd share price is currently ₹281.34, up by ₹12.18 (4.53%) from its previous closing price of ₹269.16. The share price has gained 8.24% over the past month and declined -52.83% over the past year. The stock's 52-week low and high are ₹204.66 and ₹496.00, respectively. Shivalik Rasayan Ltd has a market capitalisation of ₹ 430.00 Cr. The share price was last updated on 25 Aug 2026, 03:29 PM IST.

Shivalik Rasayan Ltd

SHIVALIK

₹0.00

₹12.18

4.53%

Chemicals

₹0.00(%)1D

Updated: 25 Aug 2026, 03:29:53 pm IST

Market Data

Open Price

₹266.22

Prev. Close

₹269.16

₹257.11

Day Low

₹281.34

Day High

₹204.66

52 Week Low

₹496.00

52 Week High

ChemicalsPesticides & Agrochemicals

CategorySmall Cap

Fundamentals

Quick Bite

Price To Earnings Ratio

32.41

Sector PE

30.74

PB Ratio

1.29

Sector PB

4.30

EPS

8.68

Dividend Yield

0.08

Today's Volume

31.156 K

5 Day Avg. Volume

40.540 K

PEG Ratio

1.09

Market Cap.

₹ 430.00 Cr.

StockGro Trade views

Technical Analysis

Forecasts 🧭

Financials

Corporate Actions

Actions	Ex-Date	Record-Date
DividendsFinal Dividend of 10% at ₹0.5/Share	21-Sep-2026	21-Sep-2026
DividendsFinal Dividend of 10% at ₹0.5/Share	19-Sep-2025	20-Sep-2025
DividendsFinal Dividend of 10% at ₹0.5/Share	20-Sep-2024	22-Sep-2024

Mutual Fund Ownership

Mutual Fund Ownership will be available shortly.

About Shivalik Rasayan Ltd 👋

Shivalik Rasayan Limited is an India-based company. The Company's segments are engaged in agrochemicals, active pharma ingredients (API), and pharma formulation. It is the producer of Malathion Technical and Dimethoate Technical. Malathion Technical is a non-systemic, wide spectrum organophosphorus (OP) based contact insecticide. Dimethoate Technical is used in preparation of formulations used in the control of a range of insects and mites. It also manufactures organophosphorus-based insecticides and chemicals. It has a diverse product range and product mix in order to serve consumer requirements. The APIs are being developed and manufactured in the niche area of oncology, ARVs, cardiovascular, metabolic disorders and immunology. It offers solutions from product selection to development to commercialization for a range of oncology and non-oncology products. The Company's oncology products include Azacitidine, Busulfan, Bortezomib, and various others.